Navigation Links
New Clinical Trial Review: Leukemia Patients Treated by Bellicum Pharmaceuticals -- 91% remission, 94% Survival (median follow-up 301 Days) Source: Pluvia Research
Date:4/10/2017

April 10, 2017, a new clinical trial report released today compares the significance of historic results treating Acute Leukemia patients vs clinical trial data reported by Bellicum Pharmaceuticals (NASDAQ: BLCM). The clinical trial review was released by Pluvia Securities Research (PSR).

The report reviews data from 122 malignant and non-malignant patients treated with BPX-501 (Bellicum Pharmaceuticals, clinical trial identifier NCT01865617 & NCT02065869). Leukemia patients treated by Bellicum, (n=35) had an overall survival rate of 94% at 6 months compared to a historical 6 month leukemia survival rate of 78% (source: National Donor Marrow Program)

56 patients with non-malignant blood disorders are also treated in the Bellicum trial. These include patients with Sickle Cell disease, Thalassemia Major and Wiscott-Aldrich. The report issued by PSR compares historical survival of these diseases at 1yr (82-92%) with 100% survival of patients treated by Bellicum BPX-501.

The full PSR Clinical Trial Review of Bellicum BPX-501 is available for free download (here)

For Additional Information Contact:
Steve Pluvia
Pluvia Research
801.824.1549

Read the full story at http://www.prweb.com/releases/2017/04/prweb14229071.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Allegheny Health Network Clinical Trial Examines Regorafenib as Maintenance Therapy for Colon Cancer
2. DrugDev Thought Leaders Share Experience and Insights on How Transformative Technology Improves Clinical Trials at Premier Pharma and Biotech Industry Conferences in Q2
3. Catalent Expands Kansas City Clinical Storage and Secondary Packaging Capabilities to Meet Growing Demand for Cold Chain Services
4. New DrugDev Educational Webinar Reveals How Biotechs and Smaller Pharmaceutical Companies Gain Site Attention and Engagement by Optimizing Clinical Trial Payments
5. FDAnews Announces — Medical Device Clinical Evaluation Reports: Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance Webinar, April 4, 2017
6. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
7. Intrinsic Imaging Awarded Phase II Immuno-Oncology Clinical Trial for the Treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer
8. Challenges and Innovation in Clinical Trial Supply to be Presented by Catalent Experts at Upcoming Conferences
9. Peanut Patch Continues to Show Promise in Extension of Latest Clinical Trial
10. New Clinical Data on Cryoablation For The Treatment Of Early Stage Breast Cancer To Be Presented At Susan G. Komen San Diego
11. ERT Clinical Trial Oversight Selected by Premier Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/9/2018)... ... August 09, 2018 , ... ... engaged as an Operating Partner and will have an exclusive relationship with the ... in the firm’s strategic planning, human capital sourcing, and deal origination, evaluation and ...
(Date:8/7/2018)... ... August 07, 2018 , ... The American Psychiatric ... to receive the 2018 Board of Directors Student Scholarship . The APNA ... psychiatric-mental health nursing and develop the next generation of leaders in the profession. ...
(Date:8/2/2018)... ... 2018 , ... Dr. Srini Pillay , best-selling author of TINKER ... could care less, demonstrating a “whatever” attitude toward life, people, and situations around them. ... often overlooked reason relates to being overworked. Called self-regulation depletion (SRD), this condition occurs ...
(Date:8/2/2018)... ... August 02, 2018 , ... A ... of topics in acute pain management. In The Role of Acute Care in ... Prescribing Engagement Network—an innovative approach to the opioid epidemic launched in the state ...
(Date:8/2/2018)... ... August 02, 2018 , ... Tunstall Americas has launched their ... can partner with Tunstall Americas for After-hours call-handling, Overflow call-handling, and Appointment Scheduling ... expand their suite of Patient Access Solutions, and gives their existing and new ...
Breaking Medicine News(10 mins):
(Date:8/7/2018)... ... August 07, 2018 , ... ... appointment of Richard A. Stark to assume the role of Sanarus Technologies President, effective immediately. ... years of strategic development, marketing and sales experience in medical device toward finding new ...
(Date:8/3/2018)... ... ... In order to improve safety for everyone throughout the summer, personal injury ... risks of injury that many amusement park rides present during the summer months. ... thrilling ride on a roller coaster. Unfortunately, these fun times can quickly turn dangerous ...
(Date:8/2/2018)... ... August 02, 2018 , ... ... gummy smile for custom crown lengthening treatment at his Eden Prairie, ... line and an unsteady self-conscious. Using decades of experience, Dr. Sanchez is excited ...
Breaking Medicine Technology: